Mumbai, November 17, 2016: UBM India, India's leading exhibition organizer, launched the India Pharma Week, a bouquet of over 10 trend-setting activities across the city of Mumbai, to mark the special 10th anniversary of CPhI & P-MEC India 2016, its flagship event and the world’s leading pharma networking event.

The inauguration was followed by the Pre-Connect Congress that set the weeklong activities in motion. The launch event served as an opportunity for global players to learn about India’s pharma regulatory requirements, growth and emerging segments for future business. The series of panel discussions included trending topics such as ‘Exploring Conventional and Unconventional Avenues to Enhance Pharmaceutical Export Potential’; ‘Mergers and Acquisition – Driving force for Indian Pharma Sector’; ‘Biosimilars – The next Big Thing; Quality Compliance – A Cultural Pre-Requisite Or External Obligation?’ and ‘Make in India – A Pharma Perspective.’

Speaking at the inauguration of the India Pharma Week, Mr Yogesh Mudras, Managing Director, UBM India said, "The India Pharma Week is a melting pot of ideas and a wholesome knowledge sharing avenue through which our flagship pharma event, the CPhI&P-MEC goes beyond the realm of a wall-bound show to one with considerable intellectual value addition. It provides key stakeholders a chance to interact, align, partner, learn, share as well as identify key opportunities unfolding in the developed as well as emerging markets. With a focus on the pillars of business, knowledge, leadership, innovation, recognition and networking, we at UBM India are honoured to be the catalysts of change in the pharma industry – equally supported by the doyens and innovators from the sector.”